ReviewOxidative medicine and cellular longevity2022
Insights into Nanopesticides for Ticks: The Superbugs of Livestock.
Review in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 32 citations in OpenAlex.
- Development and characterization of ivermectin nanoformulations for topical acaricidal activity against Rhipicephalus sanguineus ticks.Scientific reports · 2026Article
- Assessment of Chlorella vulgaris as a biological control agent against tortoise tick Hyalomma aegyptium (Acari: Ixodidae) in Egypt.Scientific reports · 2025Article
- Current Tick Control Strategies and Prospects for Using Nanotechnology as an Efficient Alternative-A Review.Veterinary sciences · 2025Review
- Green Synthesis of Uncoated and Olive Leaf Extract-Coated Silver Nanoparticles: Sunlight Photocatalytic, Antiparasitic, and Antifungal Activities.International journal of molecular sciences · 2024Article
- High Antiparasitic and Antimicrobial Performance of Biosynthesized NiO Nanoparticles via Wasted Olive Leaf Extract.International journal of nanomedicine · 2024Article
- Application of Cypermethrin-Coated ZnS and ZnO Nanoparticles againstPathogens (Basel, Switzerland) · 2023Article
- Nanoparticles as Potent Agents for Treatment ofCurrent therapeutic research, clinical and experimental · 2023Review
- Insights into nanoparticles-induced neurotoxicity and cope up strategies.Frontiers in neuroscience · 2023Review
- Nanoparticles: A Potential and Effective Method to Control Insect-Borne Diseases.Bioinorganic chemistry and applications · 2023Review
- Acaricidal Potential and Ecotoxicity of Metallic Nano-Pesticides Used against the Major Life Stages ofLife (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Livestock is an integral part of agriculture countries where ticks play significant role as potent pests causing considerable losses to economy and health. Drug resistance has made these pests supersede conventional therapies and control programs Nanotechnology here comes as an advancing and significant candidate alternatively able to reverse drug resistance. Nanoparticles, hence, against ticks may better be considered as nanopesticides that act in ways other than conventional drug efficacies. The methods of nanoparticles production include green synthesis, chemical synthesis, and arthropod-based synthesis. Pros and cons of these nanopesticides are by no means neglectable. Studies are fewer than needed to comprehensively discuss nanopesticides. Current review thus systematically covers aspects of ticks as livestock pests, their drug resistance, advent of nanotechnology against pests, their production methodologies, mechanisms of actions of ticks, and current limitations. This review opens several avenues for further research on nanoparticles as nanopesticides against ticks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.